Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block for Pain Control After Vaginal Reconstructive Surgery
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Pelvic Organ Prolapse, Surgery, Postoperative Pain
In brief
To test the hypothesis that preoperative injections along the levator ani muscles and pudendal nerve with bupivacaine and dexamethasone improve pain control after vaginal apical reconstructive surgery. A three-arm, double-blinded, randomized controlled trial of a total of 75 women will be performed. The study population will be adult women (\>18 years of age) with uterovaginal or vaginal vault prolapse who have been scheduled for native tissue vaginal reconstructive surgery which includes an apical support procedure. Participants will be enrolled prior to surgery. The procedure will involved four injection sites: the bilateral levator ani muscles via a transobturator approach and bilateral pudendal nerves via a transvaginal approach. Random assignment will occur to one of three study arms: combined arm (20 milliliters bupivacaine/dexamethasone solution divided between the 4 injection sites), bupivacaine arm (20 milliliters bupivacaine divided between the 4 injection sites), or placebo arm (20 milliliters saline divided between the 4 injection sites).
Key facts
- Study ID
- NCT03040011
- Run by
- Lauren Giugale, MD
- People needed
- 79
- Starts
- 2017-06-01
- Expected to finish
- 2019-08-05
- Last updated by the study team
- 2020-03-09
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Women ages 18 or older who are scheduled for a vaginal native tissue repair with apical support procedure including uterosacral ligament suspension, sacrospinous ligament fixation, or colpectomy and colpocleisis with or without levator myorrhaphy
- Concomitant procedures including hysterectomy, anterior and posterior colporrhaphies , perineorrhaphies and midurethral sling placements are acceptable and do not result in exclusion
- Available for at least 12 weeks of follow-up
- Able to undergoing general anesthesia
You may not qualify if…
- Planned mesh-augmented apical support procedure (placement of synthetic midurethral sling is acceptable and not considered an exclusion criteria)
- Planned mesh excision
- Laparoscopic, robotic or abdominal surgery
- Known adverse reaction or allergy to intervention medication
- Evidence of fistula or known infection (vulvovaginal cellulitis, abscess, abdominopelvic infection, or systemic fungal infection)
- Chronic pelvic pain as an active issue
- Daily opiate consumption for any indication
- History of pelvic radiation
- Chronic steroid use
- Diabetes mellitus
- Known HIV/AIDS or immunosuppression secondary to transplant related medications
- Planned surgery under regional anesthesia
- Non-English speaking or inability to complete questionnaires
- Bleeding disorders that would impair a patient's clotting ability
- Weight less than 50kg
Where it is running
- Magee-Womens Hospital of UPMC — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.